growth pillar – Talk Bio

Actionable Insights Powered by AI

Sanofi Eyes COPD Treatment as Major Growth Driver for Dupixent, Says CEO

Sanofi, Dupixent, COPD, growth pillar, immunology, CEO, treatment, expansion, clinical trials, asthma, atopic dermatitis.